These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17928740)

  • 1. Lifestyle-related diseases of the digestive system: a new in vitro model of hepatitis C virion production: application of basic research on hepatitis C virus to clinical medicine.
    Saito S; Heller T; Yoneda M; Takahashi H; Nakajima A; Liang JT
    J Pharmacol Sci; 2007 Oct; 105(2):138-44. PubMed ID: 17928740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro model of hepatitis C virion production.
    Heller T; Saito S; Auerbach J; Williams T; Moreen TR; Jazwinski A; Cruz B; Jeurkar N; Sapp R; Luo G; Liang TJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2579-83. PubMed ID: 15701697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production of infectious hepatitis C virus in cell culture].
    Kato T; Wakita T
    Uirusu; 2005 Dec; 55(2):287-95. PubMed ID: 16557015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primer on the molecular virology of hepatitis C.
    Moradpour D; Blum HE
    Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening.
    Zhang Y; Weady P; Duggal R; Hao W
    Antimicrob Agents Chemother; 2008 Feb; 52(2):666-74. PubMed ID: 18039917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
    Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation systems for anti-HCV drugs.
    Moriishi K; Matsuura Y
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models for hepatitis C virus (HCV): new opportunities for combating hepatitis C.
    Trujillo-Murillo Kdel C; Garza-Rodríguez Mdel L; Martínez-Rodríguez HG; Barrera-Saldaña HA; Bosques-Padilla F; Ramos-Jiménez J; Rivas-Estilla AM
    Ann Hepatol; 2004; 3(2):54-62. PubMed ID: 15257247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
    Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
    Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.
    Horscroft N; Lai VC; Cheney W; Yao N; Wu JZ; Hong Z; Zhong W
    Antivir Chem Chemother; 2005; 16(1):1-12. PubMed ID: 15739617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of infectious hepatitis C virus of various genotypes in cell cultures.
    Kato T; Matsumura T; Heller T; Saito S; Sapp RK; Murthy K; Wakita T; Liang TJ
    J Virol; 2007 May; 81(9):4405-11. PubMed ID: 17301131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
    Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
    Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.
    Masaki T; Suzuki R; Saeed M; Mori K; Matsuda M; Aizaki H; Ishii K; Maki N; Miyamura T; Matsuura Y; Wakita T; Suzuki T
    J Virol; 2010 Jun; 84(11):5824-35. PubMed ID: 20237083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A compartmentalization model of hepatitis C virus replication: an appropriate distribution of HCV RNA for the effective replication.
    Nakabayashi J
    J Theor Biol; 2012 May; 300():110-7. PubMed ID: 22286015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
    Bukh J
    J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
    Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
    Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.